ARA-290
ARA-290, also called cibinetide, is an erythropoietin-derived peptide investigated in tissue-protection research. A small clinical pilot examined neuropathy symptoms in people with sarcoidosis.
Research topics
Read the studies →
Tendon, wound, and connective-tissue research.
This topic groups related research questions. Shared biology does not make different peptides interchangeable, or establish a clinical benefit. Compare each paper’s population, preparation, and measured outcome.
ARA-290, also called cibinetide, is an erythropoietin-derived peptide investigated in tissue-protection research. A small clinical pilot examined neuropathy symptoms in people with sarcoidosis.
Research topics
Read the studies →BPC-157 is a 15-amino-acid research peptide. Selected animal injury studies and a two-person human safety pilot explore different questions; neither establishes treatment benefit for injured patients.
Research topics
Read the studies →GHK-Cu combines a short peptide with copper. It is discussed in topical skin care and tissue-remodeling research, which should be separated from injection claims.
Research topics
Read the studies →LL-37 is a human host-defense peptide investigated in wound biology. The selected clinical study tested topical treatment in a defined ulcer population.
Research topics
Read the studies →MGF can refer to an IGF-1 splice-product context or a synthetic terminal E-peptide. A primary replication study found no apparent effect of the tested MGF peptides on muscle-cell proliferation or differentiation.
Research topics
Read the studies →PEG-MGF is a seller and research term associated with pegylated mechano-growth-factor fragments. Naming in this area can blur several distinct biological materials.
Research topics
Read the studies →PTD-DBM is an experimental motif peptide investigated in Wnt-associated hair-follicle biology. The featured work included human tissue and cells alongside mouse experiments, rather than a controlled human hair-regrowth trial.
Research topics
Read the studies →TB-500 is associated with a short thymosin beta-4 fragment. Much of the biology cited in marketing instead concerns the full-length parent peptide.
Research topics
Read the studies →Thymosin beta-4 is a full-length 43-residue peptide studied in tissue biology. The selected human study tested an ophthalmic preparation for dry eye, with negative primary endpoints.
Research topics
Read the studies →